nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—CYP3A4—Ifosfamide—testicular cancer	0.129	0.428	CbGbCtD
Flucloxacillin—CYP3A4—Vinblastine—testicular cancer	0.0684	0.227	CbGbCtD
Flucloxacillin—CYP3A4—Etoposide—testicular cancer	0.0616	0.205	CbGbCtD
Flucloxacillin—CYP3A4—Doxorubicin—testicular cancer	0.042	0.14	CbGbCtD
Flucloxacillin—Thrombocytopenia—Dactinomycin—testicular cancer	0.00227	0.00325	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00227	0.00324	CcSEcCtD
Flucloxacillin—Convulsion—Ifosfamide—testicular cancer	0.00226	0.00323	CcSEcCtD
Flucloxacillin—Erythema multiforme—Etoposide—testicular cancer	0.00223	0.00319	CcSEcCtD
Flucloxacillin—Myalgia—Ifosfamide—testicular cancer	0.00222	0.00317	CcSEcCtD
Flucloxacillin—Arthralgia—Ifosfamide—testicular cancer	0.00222	0.00317	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.0022	0.00315	CcSEcCtD
Flucloxacillin—Diarrhoea—Chlorambucil—testicular cancer	0.0022	0.00314	CcSEcCtD
Flucloxacillin—Discomfort—Ifosfamide—testicular cancer	0.00219	0.00313	CcSEcCtD
Flucloxacillin—Hypersensitivity—Vinblastine—testicular cancer	0.00217	0.0031	CcSEcCtD
Flucloxacillin—Decreased appetite—Bleomycin—testicular cancer	0.00216	0.00309	CcSEcCtD
Flucloxacillin—Vascular purpura—Epirubicin—testicular cancer	0.00214	0.00306	CcSEcCtD
Flucloxacillin—Immune system disorder—Etoposide—testicular cancer	0.00213	0.00305	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Ifosfamide—testicular cancer	0.00212	0.00304	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00211	0.00302	CcSEcCtD
Flucloxacillin—Nervous system disorder—Ifosfamide—testicular cancer	0.00208	0.00298	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Cisplatin—testicular cancer	0.00208	0.00298	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Ifosfamide—testicular cancer	0.00208	0.00298	CcSEcCtD
Flucloxacillin—Anaemia—Cisplatin—testicular cancer	0.00207	0.00297	CcSEcCtD
Flucloxacillin—Skin disorder—Ifosfamide—testicular cancer	0.00206	0.00295	CcSEcCtD
Flucloxacillin—Feeling abnormal—Bleomycin—testicular cancer	0.00205	0.00293	CcSEcCtD
Flucloxacillin—Vomiting—Chlorambucil—testicular cancer	0.00204	0.00292	CcSEcCtD
Flucloxacillin—Malaise—Cisplatin—testicular cancer	0.00202	0.00289	CcSEcCtD
Flucloxacillin—Decreased appetite—Dactinomycin—testicular cancer	0.00202	0.00288	CcSEcCtD
Flucloxacillin—Diarrhoea—Vinblastine—testicular cancer	0.00201	0.00288	CcSEcCtD
Flucloxacillin—Dysgeusia—Etoposide—testicular cancer	0.00201	0.00288	CcSEcCtD
Flucloxacillin—Leukopenia—Cisplatin—testicular cancer	0.00201	0.00287	CcSEcCtD
Flucloxacillin—Purpura—Epirubicin—testicular cancer	0.00199	0.00284	CcSEcCtD
Flucloxacillin—Vascular purpura—Doxorubicin—testicular cancer	0.00198	0.00283	CcSEcCtD
Flucloxacillin—Urticaria—Bleomycin—testicular cancer	0.00197	0.00282	CcSEcCtD
Flucloxacillin—Body temperature increased—Bleomycin—testicular cancer	0.00197	0.00281	CcSEcCtD
Flucloxacillin—Dizziness—Vinblastine—testicular cancer	0.00195	0.00278	CcSEcCtD
Flucloxacillin—Convulsion—Cisplatin—testicular cancer	0.00194	0.00278	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00194	0.00277	CcSEcCtD
Flucloxacillin—Myalgia—Cisplatin—testicular cancer	0.00191	0.00273	CcSEcCtD
Flucloxacillin—Feeling abnormal—Dactinomycin—testicular cancer	0.00191	0.00273	CcSEcCtD
Flucloxacillin—Nausea—Chlorambucil—testicular cancer	0.00191	0.00273	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Etoposide—testicular cancer	0.00191	0.00273	CcSEcCtD
Flucloxacillin—Anaemia—Etoposide—testicular cancer	0.0019	0.00272	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.0019	0.00271	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.0019	0.00271	CcSEcCtD
Flucloxacillin—Discomfort—Cisplatin—testicular cancer	0.00189	0.0027	CcSEcCtD
Flucloxacillin—Vomiting—Vinblastine—testicular cancer	0.00187	0.00268	CcSEcCtD
Flucloxacillin—Malaise—Etoposide—testicular cancer	0.00185	0.00265	CcSEcCtD
Flucloxacillin—Decreased appetite—Ifosfamide—testicular cancer	0.00185	0.00264	CcSEcCtD
Flucloxacillin—Headache—Vinblastine—testicular cancer	0.00184	0.00264	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.00184	0.00263	CcSEcCtD
Flucloxacillin—Leukopenia—Etoposide—testicular cancer	0.00184	0.00263	CcSEcCtD
Flucloxacillin—Purpura—Doxorubicin—testicular cancer	0.00184	0.00263	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00183	0.00262	CcSEcCtD
Flucloxacillin—Abdominal pain—Dactinomycin—testicular cancer	0.00183	0.00262	CcSEcCtD
Flucloxacillin—Body temperature increased—Dactinomycin—testicular cancer	0.00183	0.00262	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Cisplatin—testicular cancer	0.00183	0.00262	CcSEcCtD
Flucloxacillin—Hypersensitivity—Bleomycin—testicular cancer	0.00183	0.00262	CcSEcCtD
Flucloxacillin—Constipation—Ifosfamide—testicular cancer	0.00182	0.0026	CcSEcCtD
Flucloxacillin—Nervous system disorder—Cisplatin—testicular cancer	0.0018	0.00257	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Cisplatin—testicular cancer	0.00179	0.00257	CcSEcCtD
Flucloxacillin—Convulsion—Etoposide—testicular cancer	0.00178	0.00255	CcSEcCtD
Flucloxacillin—Skin disorder—Cisplatin—testicular cancer	0.00178	0.00254	CcSEcCtD
Flucloxacillin—Feeling abnormal—Ifosfamide—testicular cancer	0.00175	0.0025	CcSEcCtD
Flucloxacillin—Eosinophilia—Methotrexate—testicular cancer	0.00175	0.0025	CcSEcCtD
Flucloxacillin—Nausea—Vinblastine—testicular cancer	0.00175	0.0025	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00174	0.00249	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00174	0.00248	CcSEcCtD
Flucloxacillin—Discomfort—Etoposide—testicular cancer	0.00173	0.00247	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.00172	0.00246	CcSEcCtD
Flucloxacillin—Hypersensitivity—Dactinomycin—testicular cancer	0.00171	0.00244	CcSEcCtD
Flucloxacillin—Urticaria—Ifosfamide—testicular cancer	0.00169	0.00241	CcSEcCtD
Flucloxacillin—Abdominal pain—Ifosfamide—testicular cancer	0.00168	0.0024	CcSEcCtD
Flucloxacillin—Body temperature increased—Ifosfamide—testicular cancer	0.00168	0.0024	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Etoposide—testicular cancer	0.00168	0.0024	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00167	0.00239	CcSEcCtD
Flucloxacillin—Neutropenia—Methotrexate—testicular cancer	0.00165	0.00236	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Etoposide—testicular cancer	0.00164	0.00235	CcSEcCtD
Flucloxacillin—Eosinophilia—Epirubicin—testicular cancer	0.00164	0.00234	CcSEcCtD
Flucloxacillin—Skin disorder—Etoposide—testicular cancer	0.00163	0.00233	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.00159	0.00228	CcSEcCtD
Flucloxacillin—Decreased appetite—Cisplatin—testicular cancer	0.00159	0.00228	CcSEcCtD
Flucloxacillin—Diarrhoea—Dactinomycin—testicular cancer	0.00159	0.00227	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00158	0.00226	CcSEcCtD
Flucloxacillin—Vomiting—Bleomycin—testicular cancer	0.00158	0.00226	CcSEcCtD
Flucloxacillin—Rash—Bleomycin—testicular cancer	0.00157	0.00224	CcSEcCtD
Flucloxacillin—Dermatitis—Bleomycin—testicular cancer	0.00157	0.00224	CcSEcCtD
Flucloxacillin—Hypersensitivity—Ifosfamide—testicular cancer	0.00157	0.00224	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00156	0.00223	CcSEcCtD
Flucloxacillin—Renal failure—Methotrexate—testicular cancer	0.00155	0.00222	CcSEcCtD
Flucloxacillin—Neutropenia—Epirubicin—testicular cancer	0.00155	0.00221	CcSEcCtD
Flucloxacillin—Eosinophilia—Doxorubicin—testicular cancer	0.00152	0.00217	CcSEcCtD
Flucloxacillin—Feeling abnormal—Cisplatin—testicular cancer	0.00151	0.00216	CcSEcCtD
Flucloxacillin—Haematuria—Methotrexate—testicular cancer	0.0015	0.00215	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Methotrexate—testicular cancer	0.00149	0.00213	CcSEcCtD
Flucloxacillin—Nausea—Bleomycin—testicular cancer	0.00148	0.00211	CcSEcCtD
Flucloxacillin—Vomiting—Dactinomycin—testicular cancer	0.00147	0.00211	CcSEcCtD
Flucloxacillin—Agranulocytosis—Methotrexate—testicular cancer	0.00147	0.0021	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00146	0.00209	CcSEcCtD
Flucloxacillin—Rash—Dactinomycin—testicular cancer	0.00146	0.00209	CcSEcCtD
Flucloxacillin—Decreased appetite—Etoposide—testicular cancer	0.00146	0.00209	CcSEcCtD
Flucloxacillin—Diarrhoea—Ifosfamide—testicular cancer	0.00145	0.00208	CcSEcCtD
Flucloxacillin—Renal failure—Epirubicin—testicular cancer	0.00145	0.00207	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Etoposide—testicular cancer	0.00145	0.00207	CcSEcCtD
Flucloxacillin—Body temperature increased—Cisplatin—testicular cancer	0.00145	0.00207	CcSEcCtD
Flucloxacillin—Jaundice—Epirubicin—testicular cancer	0.00144	0.00206	CcSEcCtD
Flucloxacillin—Constipation—Etoposide—testicular cancer	0.00144	0.00205	CcSEcCtD
Flucloxacillin—Neutropenia—Doxorubicin—testicular cancer	0.00143	0.00205	CcSEcCtD
Flucloxacillin—Hepatitis—Methotrexate—testicular cancer	0.00141	0.00202	CcSEcCtD
Flucloxacillin—Haematuria—Epirubicin—testicular cancer	0.00141	0.00201	CcSEcCtD
Flucloxacillin—Dizziness—Ifosfamide—testicular cancer	0.00141	0.00201	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Methotrexate—testicular cancer	0.0014	0.002	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Epirubicin—testicular cancer	0.00139	0.002	CcSEcCtD
Flucloxacillin—Urethral disorder—Methotrexate—testicular cancer	0.00139	0.00198	CcSEcCtD
Flucloxacillin—Feeling abnormal—Etoposide—testicular cancer	0.00138	0.00198	CcSEcCtD
Flucloxacillin—Nausea—Dactinomycin—testicular cancer	0.00138	0.00197	CcSEcCtD
Flucloxacillin—Agranulocytosis—Epirubicin—testicular cancer	0.00138	0.00197	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Etoposide—testicular cancer	0.00137	0.00196	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00135	0.00194	CcSEcCtD
Flucloxacillin—Vomiting—Ifosfamide—testicular cancer	0.00135	0.00193	CcSEcCtD
Flucloxacillin—Hypersensitivity—Cisplatin—testicular cancer	0.00135	0.00193	CcSEcCtD
Flucloxacillin—Renal failure—Doxorubicin—testicular cancer	0.00134	0.00192	CcSEcCtD
Flucloxacillin—Rash—Ifosfamide—testicular cancer	0.00134	0.00192	CcSEcCtD
Flucloxacillin—Dermatitis—Ifosfamide—testicular cancer	0.00134	0.00191	CcSEcCtD
Flucloxacillin—Erythema multiforme—Methotrexate—testicular cancer	0.00134	0.00191	CcSEcCtD
Flucloxacillin—Urticaria—Etoposide—testicular cancer	0.00133	0.00191	CcSEcCtD
Flucloxacillin—Jaundice—Doxorubicin—testicular cancer	0.00133	0.0019	CcSEcCtD
Flucloxacillin—Abdominal pain—Etoposide—testicular cancer	0.00133	0.0019	CcSEcCtD
Flucloxacillin—Body temperature increased—Etoposide—testicular cancer	0.00133	0.0019	CcSEcCtD
Flucloxacillin—Hepatitis—Epirubicin—testicular cancer	0.00132	0.00189	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Epirubicin—testicular cancer	0.00131	0.00187	CcSEcCtD
Flucloxacillin—Haematuria—Doxorubicin—testicular cancer	0.0013	0.00186	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Epirubicin—testicular cancer	0.0013	0.00186	CcSEcCtD
Flucloxacillin—Urethral disorder—Epirubicin—testicular cancer	0.0013	0.00186	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00129	0.00185	CcSEcCtD
Flucloxacillin—Immune system disorder—Methotrexate—testicular cancer	0.00128	0.00183	CcSEcCtD
Flucloxacillin—Agranulocytosis—Doxorubicin—testicular cancer	0.00127	0.00182	CcSEcCtD
Flucloxacillin—Nausea—Ifosfamide—testicular cancer	0.00126	0.00181	CcSEcCtD
Flucloxacillin—Diarrhoea—Cisplatin—testicular cancer	0.00125	0.00179	CcSEcCtD
Flucloxacillin—Erythema multiforme—Epirubicin—testicular cancer	0.00125	0.00179	CcSEcCtD
Flucloxacillin—Hypersensitivity—Etoposide—testicular cancer	0.00124	0.00177	CcSEcCtD
Flucloxacillin—Hepatitis—Doxorubicin—testicular cancer	0.00123	0.00175	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Doxorubicin—testicular cancer	0.00121	0.00173	CcSEcCtD
Flucloxacillin—Dysgeusia—Methotrexate—testicular cancer	0.00121	0.00172	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Doxorubicin—testicular cancer	0.0012	0.00172	CcSEcCtD
Flucloxacillin—Urethral disorder—Doxorubicin—testicular cancer	0.0012	0.00172	CcSEcCtD
Flucloxacillin—Immune system disorder—Epirubicin—testicular cancer	0.0012	0.00171	CcSEcCtD
Flucloxacillin—Vomiting—Cisplatin—testicular cancer	0.00116	0.00167	CcSEcCtD
Flucloxacillin—Erythema multiforme—Doxorubicin—testicular cancer	0.00116	0.00166	CcSEcCtD
Flucloxacillin—Rash—Cisplatin—testicular cancer	0.00115	0.00165	CcSEcCtD
Flucloxacillin—Dermatitis—Cisplatin—testicular cancer	0.00115	0.00165	CcSEcCtD
Flucloxacillin—Diarrhoea—Etoposide—testicular cancer	0.00115	0.00164	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Methotrexate—testicular cancer	0.00114	0.00163	CcSEcCtD
Flucloxacillin—Anaemia—Methotrexate—testicular cancer	0.00114	0.00163	CcSEcCtD
Flucloxacillin—Dysgeusia—Epirubicin—testicular cancer	0.00113	0.00161	CcSEcCtD
Flucloxacillin—Malaise—Methotrexate—testicular cancer	0.00111	0.00159	CcSEcCtD
Flucloxacillin—Dizziness—Etoposide—testicular cancer	0.00111	0.00159	CcSEcCtD
Flucloxacillin—Immune system disorder—Doxorubicin—testicular cancer	0.00111	0.00158	CcSEcCtD
Flucloxacillin—Leukopenia—Methotrexate—testicular cancer	0.0011	0.00158	CcSEcCtD
Flucloxacillin—Nausea—Cisplatin—testicular cancer	0.00109	0.00156	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Epirubicin—testicular cancer	0.00107	0.00153	CcSEcCtD
Flucloxacillin—Convulsion—Methotrexate—testicular cancer	0.00107	0.00153	CcSEcCtD
Flucloxacillin—Vomiting—Etoposide—testicular cancer	0.00107	0.00153	CcSEcCtD
Flucloxacillin—Anaemia—Epirubicin—testicular cancer	0.00107	0.00152	CcSEcCtD
Flucloxacillin—Rash—Etoposide—testicular cancer	0.00106	0.00151	CcSEcCtD
Flucloxacillin—Dermatitis—Etoposide—testicular cancer	0.00106	0.00151	CcSEcCtD
Flucloxacillin—Headache—Etoposide—testicular cancer	0.00105	0.0015	CcSEcCtD
Flucloxacillin—Myalgia—Methotrexate—testicular cancer	0.00105	0.0015	CcSEcCtD
Flucloxacillin—Arthralgia—Methotrexate—testicular cancer	0.00105	0.0015	CcSEcCtD
Flucloxacillin—Dysgeusia—Doxorubicin—testicular cancer	0.00104	0.00149	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00104	0.00149	CcSEcCtD
Flucloxacillin—Malaise—Epirubicin—testicular cancer	0.00104	0.00149	CcSEcCtD
Flucloxacillin—Discomfort—Methotrexate—testicular cancer	0.00104	0.00148	CcSEcCtD
Flucloxacillin—Leukopenia—Epirubicin—testicular cancer	0.00103	0.00148	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Methotrexate—testicular cancer	0.00101	0.00144	CcSEcCtD
Flucloxacillin—Convulsion—Epirubicin—testicular cancer	0.000999	0.00143	CcSEcCtD
Flucloxacillin—Nausea—Etoposide—testicular cancer	0.000997	0.00143	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000989	0.00142	CcSEcCtD
Flucloxacillin—Nervous system disorder—Methotrexate—testicular cancer	0.000986	0.00141	CcSEcCtD
Flucloxacillin—Anaemia—Doxorubicin—testicular cancer	0.000986	0.00141	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Methotrexate—testicular cancer	0.000984	0.00141	CcSEcCtD
Flucloxacillin—Myalgia—Epirubicin—testicular cancer	0.000981	0.0014	CcSEcCtD
Flucloxacillin—Arthralgia—Epirubicin—testicular cancer	0.000981	0.0014	CcSEcCtD
Flucloxacillin—Skin disorder—Methotrexate—testicular cancer	0.000976	0.0014	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000974	0.00139	CcSEcCtD
Flucloxacillin—Discomfort—Epirubicin—testicular cancer	0.000969	0.00139	CcSEcCtD
Flucloxacillin—Malaise—Doxorubicin—testicular cancer	0.000962	0.00138	CcSEcCtD
Flucloxacillin—Leukopenia—Doxorubicin—testicular cancer	0.000955	0.00137	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Epirubicin—testicular cancer	0.000941	0.00135	CcSEcCtD
Flucloxacillin—Convulsion—Doxorubicin—testicular cancer	0.000924	0.00132	CcSEcCtD
Flucloxacillin—Nervous system disorder—Epirubicin—testicular cancer	0.000922	0.00132	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Epirubicin—testicular cancer	0.000921	0.00132	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000916	0.00131	CcSEcCtD
Flucloxacillin—Skin disorder—Epirubicin—testicular cancer	0.000914	0.00131	CcSEcCtD
Flucloxacillin—Arthralgia—Doxorubicin—testicular cancer	0.000908	0.0013	CcSEcCtD
Flucloxacillin—Myalgia—Doxorubicin—testicular cancer	0.000908	0.0013	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000902	0.00129	CcSEcCtD
Flucloxacillin—Discomfort—Doxorubicin—testicular cancer	0.000897	0.00128	CcSEcCtD
Flucloxacillin—Dyspepsia—Methotrexate—testicular cancer	0.000885	0.00127	CcSEcCtD
Flucloxacillin—Decreased appetite—Methotrexate—testicular cancer	0.000874	0.00125	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Doxorubicin—testicular cancer	0.00087	0.00124	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000868	0.00124	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000857	0.00123	CcSEcCtD
Flucloxacillin—Nervous system disorder—Doxorubicin—testicular cancer	0.000854	0.00122	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000852	0.00122	CcSEcCtD
Flucloxacillin—Skin disorder—Doxorubicin—testicular cancer	0.000845	0.00121	CcSEcCtD
Flucloxacillin—Feeling abnormal—Methotrexate—testicular cancer	0.000828	0.00118	CcSEcCtD
Flucloxacillin—Dyspepsia—Epirubicin—testicular cancer	0.000828	0.00118	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000822	0.00118	CcSEcCtD
Flucloxacillin—Decreased appetite—Epirubicin—testicular cancer	0.000818	0.00117	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000812	0.00116	CcSEcCtD
Flucloxacillin—Constipation—Epirubicin—testicular cancer	0.000804	0.00115	CcSEcCtD
Flucloxacillin—Urticaria—Methotrexate—testicular cancer	0.000799	0.00114	CcSEcCtD
Flucloxacillin—Abdominal pain—Methotrexate—testicular cancer	0.000795	0.00114	CcSEcCtD
Flucloxacillin—Body temperature increased—Methotrexate—testicular cancer	0.000795	0.00114	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000793	0.00113	CcSEcCtD
Flucloxacillin—Feeling abnormal—Epirubicin—testicular cancer	0.000775	0.00111	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000769	0.0011	CcSEcCtD
Flucloxacillin—Dyspepsia—Doxorubicin—testicular cancer	0.000766	0.0011	CcSEcCtD
Flucloxacillin—Decreased appetite—Doxorubicin—testicular cancer	0.000757	0.00108	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000751	0.00107	CcSEcCtD
Flucloxacillin—Urticaria—Epirubicin—testicular cancer	0.000747	0.00107	CcSEcCtD
Flucloxacillin—Constipation—Doxorubicin—testicular cancer	0.000744	0.00106	CcSEcCtD
Flucloxacillin—Abdominal pain—Epirubicin—testicular cancer	0.000744	0.00106	CcSEcCtD
Flucloxacillin—Body temperature increased—Epirubicin—testicular cancer	0.000744	0.00106	CcSEcCtD
Flucloxacillin—Hypersensitivity—Methotrexate—testicular cancer	0.000741	0.00106	CcSEcCtD
Flucloxacillin—Feeling abnormal—Doxorubicin—testicular cancer	0.000717	0.00103	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000712	0.00102	CcSEcCtD
Flucloxacillin—Hypersensitivity—Epirubicin—testicular cancer	0.000693	0.000991	CcSEcCtD
Flucloxacillin—Urticaria—Doxorubicin—testicular cancer	0.000691	0.000989	CcSEcCtD
Flucloxacillin—Abdominal pain—Doxorubicin—testicular cancer	0.000688	0.000984	CcSEcCtD
Flucloxacillin—Body temperature increased—Doxorubicin—testicular cancer	0.000688	0.000984	CcSEcCtD
Flucloxacillin—Diarrhoea—Methotrexate—testicular cancer	0.000688	0.000984	CcSEcCtD
Flucloxacillin—Dizziness—Methotrexate—testicular cancer	0.000665	0.000951	CcSEcCtD
Flucloxacillin—Diarrhoea—Epirubicin—testicular cancer	0.000644	0.000921	CcSEcCtD
Flucloxacillin—Hypersensitivity—Doxorubicin—testicular cancer	0.000641	0.000917	CcSEcCtD
Flucloxacillin—Vomiting—Methotrexate—testicular cancer	0.000639	0.000914	CcSEcCtD
Flucloxacillin—Rash—Methotrexate—testicular cancer	0.000634	0.000906	CcSEcCtD
Flucloxacillin—Dermatitis—Methotrexate—testicular cancer	0.000633	0.000906	CcSEcCtD
Flucloxacillin—Headache—Methotrexate—testicular cancer	0.00063	0.000901	CcSEcCtD
Flucloxacillin—Dizziness—Epirubicin—testicular cancer	0.000622	0.00089	CcSEcCtD
Flucloxacillin—Vomiting—Epirubicin—testicular cancer	0.000598	0.000855	CcSEcCtD
Flucloxacillin—Nausea—Methotrexate—testicular cancer	0.000597	0.000854	CcSEcCtD
Flucloxacillin—Diarrhoea—Doxorubicin—testicular cancer	0.000596	0.000852	CcSEcCtD
Flucloxacillin—Rash—Epirubicin—testicular cancer	0.000593	0.000848	CcSEcCtD
Flucloxacillin—Dermatitis—Epirubicin—testicular cancer	0.000593	0.000847	CcSEcCtD
Flucloxacillin—Headache—Epirubicin—testicular cancer	0.000589	0.000843	CcSEcCtD
Flucloxacillin—Dizziness—Doxorubicin—testicular cancer	0.000576	0.000823	CcSEcCtD
Flucloxacillin—Nausea—Epirubicin—testicular cancer	0.000559	0.000799	CcSEcCtD
Flucloxacillin—Vomiting—Doxorubicin—testicular cancer	0.000553	0.000791	CcSEcCtD
Flucloxacillin—Rash—Doxorubicin—testicular cancer	0.000549	0.000785	CcSEcCtD
Flucloxacillin—Dermatitis—Doxorubicin—testicular cancer	0.000548	0.000784	CcSEcCtD
Flucloxacillin—Headache—Doxorubicin—testicular cancer	0.000545	0.00078	CcSEcCtD
Flucloxacillin—Nausea—Doxorubicin—testicular cancer	0.000517	0.000739	CcSEcCtD
